.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Dr. Norm's is stocked at 411 licensed dispensaries across California, with the deepest coverage in Los Angeles, Sacramento, San Diego, San Jose, and Long Beach. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Dr. Norm's shifted toward a two-pillar mix in October 2026: Edible held 55.91% share with a -16.71% year-over-year change but an 8.52% month-over-month uptick, while Capsules expanded to 34.39% share with a 374.52% year-over-year surge and a 10.63% month-over-month increase; Vapor Pens reached 9.70% share with 0.19% year-over-year and 27.11% month-over-month growth. Despite brand-level sales up 18.97% year over year and average price up 16.82%, Edible volume softness is implied by its negative year-over-year while prices rose, and Capsules’ triple-digit growth likely lifted the blended average price; the pattern indicates a re-weighting from Edible toward higher-priced Capsules as a growth lever.
Positioning now leans toward premiumized dose formats: Capsules’ 34.39% share alongside a 374.52% year-over-year increase and 10.63% month-over-month gain contrasts with Edible’s -16.71% year-over-year and 8.52% month-over-month changes, suggesting Dr. Norm's is capturing functionality-seeking shoppers rather than purely occasion snacks. Holding Edible rank 19 in California alongside a 27.11% month-over-month lift in Vapor Pens and an 18.97% brand sales year-over-year rise implies a barbell stance: defend mid-pack Edible while accelerating Capsules and testing inhalable adjacency, a mix that can diversify risk and raise price realization.
Competitive Landscape
Dr. Norm's ranks #19 in CA Edible for October 2026, down 4 spots year over year from #15 but up 2 places versus July 2026 when it sat at #21; this contrasts with Wyld holding #1 both year over year and in October 2026 while growing sales by 6.2%, and Kanha / Sunderstorm maintaining #3 alongside a 24.6% sales lift, indicating rivals are adding velocity while keeping rank. With a historical peak of #14 in January 2025 and a current position of #19, the brand’s modest quarter-on-quarter climb from #21 to #19 coupled with a YoY decline suggests share stability is eroding against top-tier incumbents, and the recent uptick is recovery rather than expansion.
Notable Products
Dr. Norm's sales in October 2026 are concentrated, with the top 10 items generating 57.3% of revenue and Indica Max Tablets 20-Pack (1000mg) alone at 17.9%. That concentration sits alongside pricing that averages 15.1% below similar products, so most of its sales ride on a focused set of value-priced leaders.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
